tiprankstipranks
Facephi Biometria SA (ES:FACE)
BME:FACE
Want to see ES:FACE full AI Analyst Report?

Facephi Biometria SA (FACE) AI Stock Analysis

11 Followers

Top Page

ES:FACE

Facephi Biometria SA

(BME:FACE)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
€2.00
▼(-20.95% Downside)
Action:Reiterated
Date:06/09/26
The score is driven primarily by improving financial performance in 2025 (profitability returning, leverage improving, and operating cash flow strengthening). This is tempered by weak technical positioning (below major moving averages) and a stretched valuation (very high P/E with no dividend yield support).
Positive Factors
Revenue & Profit Turnaround
A clear revenue inflection (+20.7%) alongside a return to positive EBIT and net income in 2025 signals product-market fit and scalable licensing/transaction economics. Durable revenue and profitability recovery improves internal funding ability and reduces reliance on external capital over the medium term.
Negative Factors
Thin Net Profitability
Net margin near 1% indicates limited ability to convert revenue growth into durable shareholder returns. Thin profits constrain retained earnings for reinvestment, make results sensitive to cost inflation or pricing pressure, and require sustained margin expansion to justify ongoing investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Profit Turnaround
A clear revenue inflection (+20.7%) alongside a return to positive EBIT and net income in 2025 signals product-market fit and scalable licensing/transaction economics. Durable revenue and profitability recovery improves internal funding ability and reduces reliance on external capital over the medium term.
Read all positive factors

Facephi Biometria SA (FACE) vs. iShares MSCI Spain ETF (EWP)

Facephi Biometria SA Business Overview & Revenue Model

Company Description
Facephi Biometria, S.A. delivers advanced biometric facial recognition technology solutions, primarily targeting the banking industry across Latin America, the United States, Asia, and other international markets. The company's offerings include "...
How the Company Makes Money
Facephi generates revenue primarily by selling and licensing its biometric and digital-identity software to enterprise and institutional customers, and by providing implementation and ongoing services that support those deployments. Key revenue st...

Facephi Biometria SA Financial Statement Overview

Summary
Financials show a promising 2025 inflection: strong revenue growth (+20.7%), return to positive EBIT/net income, improved leverage (debt-to-equity ~0.33), and much stronger operating cash flow (~€7.3M). Offsetting this, profitability remains thin (~1% net margin), free cash flow is still negative (~-€1.4M), and results have been volatile with large losses in 2023–2024.
Income Statement
56
Neutral
Balance Sheet
64
Positive
Cash Flow
48
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue35.98M28.88M29.32M22.28M13.16M
Gross Profit22.75M13.21M25.90M22.92M13.46M
EBITDA7.90M-220.15K-4.77M3.30M821.13K
Net Income368.70K-8.88M-4.31M1.11M-553.90K
Balance Sheet
Total Assets48.01M49.71M45.71M32.25M18.36M
Cash, Cash Equivalents and Short-Term Investments2.21M5.70M2.90M2.05M1.39M
Total Debt7.20M10.18M12.96M7.83M6.22M
Total Liabilities26.22M30.52M25.67M17.04M9.65M
Stockholders Equity21.79M19.19M20.04M15.21M8.71M
Cash Flow
Free Cash Flow-1.42M-4.53M-664.63K-7.88M-6.15M
Operating Cash Flow7.34M724.43K853.21K-5.82M-3.60M
Investing Cash Flow-8.76M-5.28M-9.83M-2.20M-2.14M
Financing Cash Flow-919.49K7.56M9.54M8.60M1.30M

Facephi Biometria SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.53
Price Trends
50DMA
2.18
Negative
100DMA
2.25
Negative
200DMA
2.39
Negative
Market Momentum
MACD
-0.05
Positive
RSI
43.76
Neutral
STOCH
39.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:FACE, the sentiment is Negative. The current price of 2.53 is above the 20-day moving average (MA) of 2.13, above the 50-day MA of 2.18, and above the 200-day MA of 2.39, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 43.76 is Neutral, neither overbought nor oversold. The STOCH value of 39.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ES:FACE.

Facephi Biometria SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
€22.80M0.4018.33%2.83%-178.88%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
€317.23M65.504.21%21.31%-12.38%
51
Neutral
€54.22M147.22
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ES:FACE
Facephi Biometria SA
2.05
-0.67
-24.63%
ES:IZER
Izertis SA
9.08
-0.08
-0.87%
ES:SAI
Substrate Artificial Intelligence SA
0.03
-0.08
-74.76%
ES:AI
Airtificial Intelligence Structures SA
0.09
-0.02
-19.13%
ES:SCO
Seresco SA
5.95
-2.17
-26.76%
ES:ATSI
Aplicaciones y Tratamiento de Sistemas, S.A.
4.20
0.42
11.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 09, 2026